Cell index values were normalized at the time of the addition. Normalized cell index values are plotted in 1 h increments as the average of two replicates together with standard deviation. (E) Quantification of normalized cell index was performed at 72 h, by measuring the change in area under the curve compared to non-treated controls, and are presented as percentage of cell kill for 100 μg/ml cetuximab treatment or 100 μg/ml rituximab (control antibody), alone or with PBMCs (20:1). (F) Quantification of cytotoxicity was performed at 48 h, by measuring the amount of LDH released into the culture supernatant, and is presented as percentage of cytotoxicity for 100 μg/ml cetuximab treatment or 100 μg/ml rituximab (control antibody), alone or with PBMCs (20:1), compared with non-treated controls. The results are expressed as the mean ± SEM, from at least three independent experiments. *p < 0.05 from respective SW480-Empty treated cells; † p < 0.01 and ‡ p < 0.05 from the respective cell line treated with rituximab and PBMCs.
